Stay updated on IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial
Sign up to get notified when there's something new on the IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial page.

Latest updates to the IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe Study Protocol and Statistical Analysis Plan PDF revision label changed from v3.5.3 to v3.5.4, signaling an updated document version. The page's core study details remain unchanged.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision tag was updated from v3.5.2 to v3.5.3, indicating a new published version of the content. No substantive content changes are indicated by this update.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision number updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check58 days agoChange Detected- Added the term 'Squamous cell carcinoma of the head and neck' to the study's conditions / MeSH terms to reflect the applicable disease category.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 across the site. No changes to study content or functionality are indicated.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial page.